Skip to main content
Erschienen in: International Journal of Diabetes in Developing Countries 2/2017

15.09.2016 | Original Article

The analysis of the cost and amputation rates of hospitalized diabetic foot infection patients

verfasst von: Gül Karagöz, Ayten Kadanalı, Sinan Öztürk, Sinan Öztürk, Şule Eren Çakar, Şenol Çomoğlu, Fidan Doğan

Erschienen in: International Journal of Diabetes in Developing Countries | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Direct and indirect costs of diabetes and its complications figure prominently in health care expenditure globally. The diabetic foot is one of the most common complications of diabetes and is usually associated with neurological and peripheral vascular problems, yielding foot ulcers and infection. The aim of this study was to analyze hospitalized diabetic foot patient costs and amputation rate changes over time. Hospitalized patients with infected diabetic foot ulcerations within a 4-year span, starting in January 2012, were retrospectively evaluated to analyze cost and amputation rate changes over time. One hundred thirty-eight diabetic patients were hospitalized and treated. Major amputation rates tended to increase; however, minor amputation rates tended to decrease over time. Mean cost per patient was $2880. The distribution of the costs according to the years was not significant. Treatment of infected diabetic foot ulceration is challenging and incurs high healthcare costs. Through intensive foot care and multidisciplinary team approaches, major amputation rates have gradually increased in recent years.
Literatur
1.
Zurück zum Zitat Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94:311–21.CrossRefPubMed Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94:311–21.CrossRefPubMed
2.
Zurück zum Zitat Lavery LA, Armstrong DG, Wunderlich RP, Tredwell J, Boulton AJ. Diabetic foot syndrome: evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease management cohort. Diabetes Care. 2003;26:1435–8.CrossRefPubMed Lavery LA, Armstrong DG, Wunderlich RP, Tredwell J, Boulton AJ. Diabetic foot syndrome: evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease management cohort. Diabetes Care. 2003;26:1435–8.CrossRefPubMed
4.
5.
Zurück zum Zitat Beaglehole R, Bonita R, Alleyne G, Horton R, Li L, Lincoln P, Mbanya JC, McKee M, Moodie R, Nishtar S, Piot P, Reddy KS, Stuckler D, Lancet NCD Action Group. UN high-level meeting on non-communicable diseases: addressing four questions. Lancet. 2011;378:449–55.CrossRefPubMed Beaglehole R, Bonita R, Alleyne G, Horton R, Li L, Lincoln P, Mbanya JC, McKee M, Moodie R, Nishtar S, Piot P, Reddy KS, Stuckler D, Lancet NCD Action Group. UN high-level meeting on non-communicable diseases: addressing four questions. Lancet. 2011;378:449–55.CrossRefPubMed
6.
Zurück zum Zitat Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJ, Armstrong DG, Deery HG, Embil JM, Joseph WS, Karchmer AW, Pinzur MS, Senneville E. Infectious Diseases Society of America. Executive summary: Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012;54:1679–84.CrossRefPubMed Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJ, Armstrong DG, Deery HG, Embil JM, Joseph WS, Karchmer AW, Pinzur MS, Senneville E. Infectious Diseases Society of America. Executive summary: Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012;54:1679–84.CrossRefPubMed
8.
Zurück zum Zitat Hoffstad O, Mitra N, Walsh J, Margolis DJ. Diabetes, lower-extremity amputation, and death. Diabetes Care. 2015;38:1852–7.CrossRefPubMed Hoffstad O, Mitra N, Walsh J, Margolis DJ. Diabetes, lower-extremity amputation, and death. Diabetes Care. 2015;38:1852–7.CrossRefPubMed
9.
Zurück zum Zitat Karakoc A, Ersoy RU, Arslan M, Toruner FB, Yetkin I. Change in amputation rate in a Turkish diabetic foot population. J Diabetes Complicat. 2004;18:169–72.CrossRefPubMed Karakoc A, Ersoy RU, Arslan M, Toruner FB, Yetkin I. Change in amputation rate in a Turkish diabetic foot population. J Diabetes Complicat. 2004;18:169–72.CrossRefPubMed
10.
Zurück zum Zitat Tabur S, Eren MA, Çelik Y, Dağ OF, Sabuncu T, Sayiner ZA, Savas E. The major predictors of amputation and length of stay in diabetic patients with acute foot ulceration. Wien Klin Wochenschr. 2015;127:45–50.CrossRefPubMed Tabur S, Eren MA, Çelik Y, Dağ OF, Sabuncu T, Sayiner ZA, Savas E. The major predictors of amputation and length of stay in diabetic patients with acute foot ulceration. Wien Klin Wochenschr. 2015;127:45–50.CrossRefPubMed
11.
Zurück zum Zitat Yesil S, Akinci B, Bayraktar F, Havitcioglu H, Karabay O, Yapar N, Demirdover C, Yener S, Yalcin M, Comlekci A, Eraslan S. Reduction of major amputations after starting a multidisciplinary diabetic foot care team: single centre experience from Turkey. Exp Clin Endocrinol Diabetes. 2009;117:345–9.CrossRefPubMed Yesil S, Akinci B, Bayraktar F, Havitcioglu H, Karabay O, Yapar N, Demirdover C, Yener S, Yalcin M, Comlekci A, Eraslan S. Reduction of major amputations after starting a multidisciplinary diabetic foot care team: single centre experience from Turkey. Exp Clin Endocrinol Diabetes. 2009;117:345–9.CrossRefPubMed
12.
Zurück zum Zitat Aksoy DY, Gürlek A, Cetinkaya Y, Oznur A, Yazici M, Ozgür F, Aydingöz U, Gedik O. Change in the amputation profile in diabetic foot in a tertiary reference center: efficacy of team working. Exp Clin Endocrinol Diabetes. 2004;112:526–30.CrossRefPubMed Aksoy DY, Gürlek A, Cetinkaya Y, Oznur A, Yazici M, Ozgür F, Aydingöz U, Gedik O. Change in the amputation profile in diabetic foot in a tertiary reference center: efficacy of team working. Exp Clin Endocrinol Diabetes. 2004;112:526–30.CrossRefPubMed
13.
Zurück zum Zitat Akcay S, Satoglu IS, Harman E, Kurtulmus A, Kazimoglu C. A retrospective analysis of amputation rates and comorbidity in patients with diabetic foot ulcer. Med Sci. 2012;1:331–40.CrossRef Akcay S, Satoglu IS, Harman E, Kurtulmus A, Kazimoglu C. A retrospective analysis of amputation rates and comorbidity in patients with diabetic foot ulcer. Med Sci. 2012;1:331–40.CrossRef
14.
Zurück zum Zitat Gonen MS, Cakir M, Gonulalan G, Ozturk M, Ipekci SH, Kosker A, Karalezli MN, Eryaman I, Durgut K, Keskin M, Seyhan N. The problems and cost-effectiveness analysis of diabetic foot infections. Turk J Endocrinol Metab. 2012;16:10–3. Gonen MS, Cakir M, Gonulalan G, Ozturk M, Ipekci SH, Kosker A, Karalezli MN, Eryaman I, Durgut K, Keskin M, Seyhan N. The problems and cost-effectiveness analysis of diabetic foot infections. Turk J Endocrinol Metab. 2012;16:10–3.
15.
Zurück zum Zitat Lavery LA, Armstrong DG, Murdoch DP, Peters EJ, Lipsky BA. Validation of the Infectious Diseases Society of America's diabetic foot infection classification system. Clin Infect Dis. 2007;44:562–5.CrossRefPubMed Lavery LA, Armstrong DG, Murdoch DP, Peters EJ, Lipsky BA. Validation of the Infectious Diseases Society of America's diabetic foot infection classification system. Clin Infect Dis. 2007;44:562–5.CrossRefPubMed
16.
Zurück zum Zitat Moxey PW, Gogalniceanu P, Hinchliffe RJ, Loftus IM, Jones KJ, Thompson MM, Holt PJ. Lower extremity amputations—a review of global variability in incidence. Diabet Med. 2011;28:1144–53.CrossRefPubMed Moxey PW, Gogalniceanu P, Hinchliffe RJ, Loftus IM, Jones KJ, Thompson MM, Holt PJ. Lower extremity amputations—a review of global variability in incidence. Diabet Med. 2011;28:1144–53.CrossRefPubMed
17.
Zurück zum Zitat Holman N, Young RJ, Jeffcoate WJ. Variation in the recorded incidence of amputation of the lower limb in England. Diabetologia. 2012;55:1919–25.CrossRefPubMed Holman N, Young RJ, Jeffcoate WJ. Variation in the recorded incidence of amputation of the lower limb in England. Diabetologia. 2012;55:1919–25.CrossRefPubMed
18.
Zurück zum Zitat Altunbaş HA, Balci MK, Karayalcin U. A retrospective analysis of hospitalized diabetic foot patients in Akdeniz University School of Medicine, Division of Endocrinology. Turk J Endocrinol Metab. 1999;3:123–7. Altunbaş HA, Balci MK, Karayalcin U. A retrospective analysis of hospitalized diabetic foot patients in Akdeniz University School of Medicine, Division of Endocrinology. Turk J Endocrinol Metab. 1999;3:123–7.
20.
Zurück zum Zitat Keskek SO, Kirim S, Yanmaz N. Estimated costs of the treatment of diabetic foot ulcers in a tertiary hospital in Turkey. Pak J Med Sci. 2014;30:968–71.PubMedPubMedCentral Keskek SO, Kirim S, Yanmaz N. Estimated costs of the treatment of diabetic foot ulcers in a tertiary hospital in Turkey. Pak J Med Sci. 2014;30:968–71.PubMedPubMedCentral
21.
Zurück zum Zitat Bao X, Yang C, Fang K, Shi M, Yu G, Hu Y. Hospitalization costs and complications in hospitalized patients with type 2 diabetes mellitus in Beijing. China J Diabetes. 2016. doi:10.1111/1753-0407.12428.PubMed Bao X, Yang C, Fang K, Shi M, Yu G, Hu Y. Hospitalization costs and complications in hospitalized patients with type 2 diabetes mellitus in Beijing. China J Diabetes. 2016. doi:10.​1111/​1753-0407.​12428.PubMed
22.
Zurück zum Zitat Elif A, Onder NT, Kayali S, Keskin Z, Yigit O. Cost analysis per patient in state hospitals according to departments (an example based on Istanbul education and research hospital). Health Care Acad J. 2015;2:40–52.CrossRef Elif A, Onder NT, Kayali S, Keskin Z, Yigit O. Cost analysis per patient in state hospitals according to departments (an example based on Istanbul education and research hospital). Health Care Acad J. 2015;2:40–52.CrossRef
23.
Zurück zum Zitat Hicks CW, Selvarajah S, Mathioudakis N, Perler BA, Freischlag JA, Black 3rd JH, Abularrage CJ. Trends and determinants of costs associated with the inpatient care of diabetic foot ulcers. J Vasc Surg. 2014;60:1247–54.CrossRefPubMed Hicks CW, Selvarajah S, Mathioudakis N, Perler BA, Freischlag JA, Black 3rd JH, Abularrage CJ. Trends and determinants of costs associated with the inpatient care of diabetic foot ulcers. J Vasc Surg. 2014;60:1247–54.CrossRefPubMed
24.
Zurück zum Zitat Hopkins RB, Burke N, Harlock J, Jegathisawaran J, Goeree R. Economic burden of illness associated with diabetic foot ulcers in Canada. BMC Health Serv Res. 2015;15:13.CrossRefPubMedPubMedCentral Hopkins RB, Burke N, Harlock J, Jegathisawaran J, Goeree R. Economic burden of illness associated with diabetic foot ulcers in Canada. BMC Health Serv Res. 2015;15:13.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Cavanagh P, Attinger C, Abbas Z, Bal A, Rojas N, Xu ZR. Cost of treating diabetic foot ulcers in five different countries. Diabetes Metab Res Rev. 2012;28(Suppl 1):107–11.CrossRefPubMed Cavanagh P, Attinger C, Abbas Z, Bal A, Rojas N, Xu ZR. Cost of treating diabetic foot ulcers in five different countries. Diabetes Metab Res Rev. 2012;28(Suppl 1):107–11.CrossRefPubMed
Metadaten
Titel
The analysis of the cost and amputation rates of hospitalized diabetic foot infection patients
verfasst von
Gül Karagöz
Ayten Kadanalı
Sinan Öztürk
Sinan Öztürk
Şule Eren Çakar
Şenol Çomoğlu
Fidan Doğan
Publikationsdatum
15.09.2016
Verlag
Springer India
Erschienen in
International Journal of Diabetes in Developing Countries / Ausgabe 2/2017
Print ISSN: 0973-3930
Elektronische ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-016-0524-3

Weitere Artikel der Ausgabe 2/2017

International Journal of Diabetes in Developing Countries 2/2017 Zur Ausgabe